Risk Mitigation News
Most Popular Risk Mitigation Story
Mitigate risks in clinical trials
Potentially valid drugs are sometimes denied FDA approval because flawed clinical data undermines efficacy and safety findings, says Health Decisions. The company notes that risk is at an all-time Read more...
Latest Headlines
- February 21, 2010
- January 30, 2010
- September 27, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
